Vitamin D and insomnia: a trial in women with deficiency, but no results yet

A hypothesis still to be tested

The abstract presents vitamin D deficiency as a potential contributor to sleep problems. However, it notes that findings from studies on supplementation and insomnia are inconsistent, with limited data on Southeast Asian populations.

The distinction matters: an association between low vitamin D levels and sleep problems is not enough to establish that correcting those levels improves insomnia. That is precisely the effect this trial seeks to measure.

A controlled trial in women with vitamin D deficiency

The protocol concerns Malaysian women aged 19 to 50 with insomnia symptoms and blood 25-hydroxyvitamin D levels below 20 ng/mL. It involves weekly vitamin D3 supplementation or a placebo for nine weeks.

Allocation is randomized, and the trial is double-blind. This design is intended to allow comparison between groups while limiting the influence of participants’ and assessors’ expectations. The abstract reports 33 participants recruited at the stated stage of progress, without presenting any comparison of outcomes between groups.

Questionnaires and actigraphy measurements

The researchers plan to assess insomnia severity using the Insomnia Severity Index and sleep quality using the Pittsburgh Sleep Quality Index. Sleep efficiency will also be assessed using actigraphy, alongside questionnaire responses.

Daytime sleepiness and functional effects are also among the outcomes being studied. Assessments are planned at baseline, midway through the intervention, and after the intervention. For now, the abstract describes these measures without reporting their results.

What this publication does not change yet

This protocol demonstrates neither an improvement in sleep nor an absence of effect. Even if favorable results are later published, their relevance would first need to be assessed in women with both vitamin D deficiency and insomnia symptoms, without automatically extrapolating to people without deficiency.

The authors consider a possible role for vitamin D as an adjunct to cognitive behavioral therapy for insomnia, but only if its efficacy is demonstrated. This remains a hypothesis, not a recommendation arising from the trial.

What we can take away

This publication outlines a way to test the hypothesis, not a reason to take vitamin D for sleep. Comparative results are still needed.